Trial intelligence / Profile preview

Posterior Tibia Nerve Neuroprolotherapy for Dysmenorrhea

NCT06294743Phase 1Recruiting

Sponsor
Taichung Armed Forces General Hospital
Start
Nov 2023
Primary completion
Dec 2025
Countries
1
01

Overview

Phase 1, randomised, open-label trial (2 arms), sponsored by Taichung Armed Forces General Hospital. Primary endpoint: Visual Analogue Scale. Started Nov 2023; status: recruiting.

Beyond the preview

Go deeper on NCT06294743.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06294743.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call